Showing results (1971-1980 of 2,436) with videos related to

Sort By:
Pageof 244
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 23, 2016
Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its OperationalizationAmaia Calderón-Larrañaga, Davide L Vetrano, Graziano Onder, et al.
Targeted Oncology|January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapyMatteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
Plos One|November 25, 2014
Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genesMichel Guipponi, Federico A Santoni, Vincent Setola, et al.
Elife|December 30, 2017
Environmental stimuli shape microglial plasticity in gliomaStefano Garofalo, Alessandra Porzia, Fabrizio Mainiero, et al.
Targeted Oncology|August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World StudyMatteo Santoni, Francesco Massari, Enrique Grande, et al.
Expert Opinion on Pharmacotherapy|February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working groupConcetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
Clinical Genitourinary Cancer|December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 StudyFernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
Therapeutic Advances in Urology|April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patientsSebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
American Journal of Human Genetics|December 30, 2019
Neuron-Derived Neurotrophic Factor Is Mutated in Congenital Hypogonadotropic HypogonadismAndrea Messina, Kristiina Pulli, Sara Santini, et al.
International Journal of Molecular Sciences|January 21, 2023
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
Pageof 244